Effects of Caffeine on Electrophysiological and Neuropsychological Indices after Sleep DeprivationDeslandes A.a · Ferreira C.a · Veiga H.a · Cagy M.b · Piedade R.a · Pompeu F.c · Ribeiro P.a, c, d
aSetor de Mapeamento Cerebral e Integração Sensório-Motora, Instituto de Psiquiatria, bCOPPE, e cEscola de Educação Física e Desportos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, e dUniversidade Castel Branco, Castelo Branco, Brasil
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Caffeine is regarded as a central nervous system (CNS) stimulant. The goal of this study was to analyze electrophysiological, motor, cognitive and behavioral changes produced by caffeine ingestion after sleep deprivation. Ten subjects were evaluated after sleep deprivation, comparing the ingestion of either 400 mg of caffeine or placebo, in a double-blind randomized study. The variables analyzed were: quantitative EEG, the event-related potential (ERP-P300) and cognitive responses. The most significant quantitative EEG results, which were characterized by moment × treatment interactions, were seen in α and Θ relative power variables. A significant decrease in relative α and Θ was observed in the caffeine group after sleep deprivation. In relation to caffeine stimulant effects, there were no significant differences in the other parameters.
© 2006 S. Karger AG, Basel
- Hollingworth HL: The influence of caffeine on the speed and quality of performance in typewriting. Psychol Rev 1912a;19:63–73.
- Sawynok J, Yaksh L: Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993;45:43–85.
- Lieberman H: The effects of ginseng, ephedrine and caffeine on cognitive performance, mood and energy. Nutr Rev 2001;59:91–102.
- Deslandes A, Veiga H, Cagy M, Piedade R, Pompeu F, Ribeiro P: Effects of caffeine on the electrophysiological, cognitive and motor responses of the central nervous system. Braz J Med Biol Res 2005;38:1077-1086.
- Patat A, Rosenzweig P, Enslen M, et al: Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects. Hum Psychopharmacol 2000;15:153–170.
- Siepmann M, Kirch W: Effects of caffeine on topographic quantitative EEG. Neuropsychobiology 2002;45:161–166.
- Lorist M, Snel J, Mulder G, Kok A: Aging, caffeine, and information processing: an event-related potential analysis. Electroencephalogr Clin Neurophysiol 1995;96:453–467.
- Debrah K, Sherwin R, Murphy J, Kerr D: Effects of caffeine on recognition of and physiological responses to hipoglycaemia in insulin-dependent diabetes. Lancet 1996;347:19–24.
- Edward S, Brice C, Craig C, Penri-Jones R: Effects of caffeine, practice, and mode of presentation on Stroop task performance. Pharmacol Biochem Behav 1996;54:309–315.
- Ruijter J, Lorist M, Snel J, Ruiter M: The influence of caffeine on sustained attention: an ERP study. Pharmacol Biochem Behav 2000;66:29–37.
- Deslandes A, Veiga H, Cagy M, Piedade R, Pompeu F, Ribeiro P: Effects of caffeine on visual evoked potential (P300) and neuromotor performance. Arq Neuropsiquiatr 2004;62:385–390.
- Seild R, Peryl A, Nicham R, Hauser E: A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 2000;19:635–642.
- Beaumont M, Batejat D, Pierard C, et al: Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. J Sleep Res 2001;10:265–276.
- Polich J, Kok A: Cognitive and biological determinants of P300: an integrative review. Biol Psychol 1995;41:103–146.
Polich J, Herbst K: P300 as a clinical assay: rationale, evolution, and findings. Int J Psychol 2000;38:3–19.
- Reeves R, Struve F, Patrick G: The effects of caffeine withdrawal on cognitive P300 auditory and visual evoked potentials. Clin Electroencephalogr 1999;30:24–27.
- Kawamura N, Maeda H, Nakamura J, Morita K, Nakazaa Y: Effects of caffeine on event-related potentials: comparison of oddball with single-tone paradigms. Psychiatry Clin Neurosci 1996;50:217–221.
- Oldfield R: The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971;9:99–113.
James EJ: Caffeine and Health, ed 1. San Diego, Academic Press, 1991.
- Dumermuth G, Ferber G, Herrmann WM, Hinrichs H, Künkel H: International Pharmaco-EEG Group (IPEG). Committee on standardization of data acquisition and analysis in pharmaco-EEG investigations. Neuropsychobiology 1987;17:213–218.
- Polich J: P300 clinical and control variability. J Clin Neurophysiol 1998;15:14–33.
- Bray C, Cahill K, Oshier J: Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults. J Investig Med 2004;52:192–201.
- Landolt H, Rétey J, Tönz K, et al: Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacology 2004;29:1933–1939.
- Pollock V, Teasdale T, Stern J, Volavka J: Effects of caffeine on resting EEG and response to sine wave modulated light. Electroencephalogr Clin Neurophysiol 1981;51:470–476.
- Gevins A, Smith ME, McEvoy LK: Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology 2002;26:27–39.
- Kraaier V, Van Huffelen AC, Wieneke GH, Van der Worp HB, Bar PR: Quantitative EEG changes due to cerebral vasoconstriction: indomethacin versus hyperventilation-induced reduction in cerebral blood flow in normal subjects. Electroencephalogr Clin Neurophysiol 1992;82:208–212.
- Fredholm B, Bättig K, Holmen J, Nehlig A, Zvartau E: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83–133.
Lorist MM, Tops M: Caffeine, fatigue and cognition: Brain Cogn2003;53:82–94.
- Strijkstra A, Beersma D, Drayer B, Halbesma N, Dann S: Subjective sleepiness correlates negatively with global alpha (8–12 Hz) and positively with central frontal theta (4–8 Hz) frequencies in the human awake electroencephalogram. Neurosci Lett 2003;340:17–20.
- Corsi-Cabrera M, Ramos J, Arce C, Guevara M, Ponce-de-Leon M, Lorenzo I: Changes in the waking EEG as a consequence of sleep and sleep deprivation. Sleep 1992;15:550–555.
- Ferreira C, Deslandes A, Moraes H, Cagy M, Pompeu F, Basile L , Piedade R, Ribeiro P: Electroencephalographic changes after one night of sleep deprivation. Arq Neuropsiquiatr 2006;64:388–393.
- Tieges Z, Ridderinkhof K, Snel J, Kok A: Caffeine strengthens action monitoring: evidence from the error-related negativity. Cogn Brain Res 2004;21:8–93.
- Foreman N, Barraclough IS, Moore C, Mehta A, Madon M: High doses of caffeine impair performance of a numerical version of the Stroop task in men. Pharmacol Biochem Behav 1989;32:399–403.
- Jones K, Harrison Y: Frontal lobe function, sleep loss and fragmented sleep. Sleep Med Rev 2001;5:463–475.
- Kenemans J, Wieleman J, Zeegers M, Verbaten M: Caffeine and Stroop Interference. Pharmacol Biochem Behav 1999;63:589–598.
- Chee M, Choo W: Functional imaging of working memory after 24 hr of total sleep deprivation. J Neurosci 2004;24:4560–4567.
- Drummond S, Brown G, Gillin J, Stricker J, Wong E, Buxton R: Altered brain response to verbal learning following sleep deprivation. Nature 2000;403:655–657.
- Bucci P, Mucci A, Volpe U, et al: Executive hypercontrol in obsessive compulsive disorder: electrophysiological and neuropsychological indices. Clin Neurophysiol 2004;115:1340–1348.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.